Literature DB >> 33561940

Magnolol and Honokiol: Two Natural Compounds with Similar Chemical Structure but Different Physicochemical and Stability Properties.

Iris Usach1, Alessandro Alaimo1, Juan Fernández1, Alessandro Ambrosini1, Sara Mocini1, Lacramioara Ochiuz2, José-Esteban Peris1.   

Abstract

Magnolia spp. extracts are known for their use in traditional Korean, Chinese, and Japanese medicine in the treatment of gastrointestinal disorders, anxiety, and allergies. Among their main components with pharmacological activity, the most relevant are magnolol and honokiol, which also show antitumoral activity. The objectives of this work were to study some physicochemical properties of both substances and their stability under different conditions of temperature, pH, and oxidation. Additionally, liposomes of honokiol (the least stable compound) were formulated and characterized. Both compounds showed pH-dependent solubility, with different solubility-pH profiles. Magnolol showed a lower solubility than honokiol at acidic pH values, but a higher solubility at alkaline pH values. The partition coefficients were similar and relatively high for both compounds (log Po/w ≈ 4.5), indicating their lipophilic nature. Honokiol was less stable than magnolol, mainly at neutral and basic pH values. To improve the poor stability of honokiol, it was suitably loaded in liposomes. The obtained liposomes were small in size (175 nm), homogeneous (polydispersity index = 0.17), highly negatively charged (-11 mV), and able to incorporate high amounts of honokiol (entrapment efficiency = 93.4%). The encapsulation of honokiol in liposomes increased its stability only at alkaline pH values.

Entities:  

Keywords:  honokiol; liposomes; magnolol; solubility; stability

Year:  2021        PMID: 33561940      PMCID: PMC7915353          DOI: 10.3390/pharmaceutics13020224

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  37 in total

Review 1.  The influence of lipophilicity in drug discovery and design.

Authors:  John A Arnott; Sonia Lobo Planey
Journal:  Expert Opin Drug Discov       Date:  2012-09-19       Impact factor: 6.098

Review 2.  Drug delivery vehicles on a nano-engineering perspective.

Authors:  Betiana Felice; Molamma P Prabhakaran; Andrea P Rodríguez; Seeram Ramakrishna
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2014-04-28       Impact factor: 7.328

3.  Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes.

Authors:  Maria Coimbra; Benedetta Isacchi; Louis van Bloois; Javier Sastre Torano; Aldo Ket; Xiaojie Wu; Femke Broere; Josbert M Metselaar; Cristianne J F Rijcken; Gert Storm; Rita Bilia; Raymond M Schiffelers
Journal:  Int J Pharm       Date:  2011-02-01       Impact factor: 5.875

4.  Antifungal activity of magnolol and honokiol.

Authors:  K H Bang; Y K Kim; B S Min; M K Na; Y H Rhee; J P Lee; K H Bae
Journal:  Arch Pharm Res       Date:  2000-02       Impact factor: 4.946

5.  Quality assessment of commercial Magnoliae officinalis Cortex by ¹H-NMR-based metabolomics and HPLC methods.

Authors:  Yong Jiang; Julie Vaysse; Véronique Gilard; Stéphane Balayssac; Sébastien Déjean; Myriam Malet-Martino; Bruno David; Christel Fiorini; Yves Barbin
Journal:  Phytochem Anal       Date:  2011-10-24       Impact factor: 3.373

6.  Anti-platelet effect of the constituents isolated from the barks and fruits of Magnolia obovata.

Authors:  Mi Kyung Pyo; Yongyook Lee; Hye Sook Yun-Choi
Journal:  Arch Pharm Res       Date:  2002-06       Impact factor: 4.946

7.  Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents.

Authors:  Qun Xu; Li-Tao Yi; Ying Pan; Xing Wang; Yu-Cheng Li; Jian-Mei Li; Cai-Ping Wang; Ling-Dong Kong
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-11-28       Impact factor: 5.067

8.  Antiinflammatory activity of methanol extract isolated from stem bark of Magnolia kobus.

Authors:  Jong Soon Kang; Ki Hoon Lee; Mi Hwa Han; Hyunju Lee; Ji-Mi Ahn; Sang-Bae Han; Gyoonhee Han; Kiho Lee; Song-Kyu Park; Hwan Mook Kim
Journal:  Phytother Res       Date:  2008-07       Impact factor: 5.878

Review 9.  Insights on the Multifunctional Activities of Magnolol.

Authors:  Jianhong Zhang; Zhixi Chen; Xianhua Huang; Weimei Shi; Rui Zhang; Meiling Chen; Hao Huang; Longhuo Wu
Journal:  Biomed Res Int       Date:  2019-05-23       Impact factor: 3.411

Review 10.  Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer.

Authors:  Abhishek Manoj Ranaware; Kishore Banik; Vishwas Deshpande; Ganesan Padmavathi; Nand Kishor Roy; Gautam Sethi; Lu Fan; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  Int J Mol Sci       Date:  2018-08-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.